Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Blog by Rima Shretta in the Centre for Tropical Medicine & Global Health (Nuffield Department of Medicine). As the COVID-19 pandemic continues its path to LMICs, its impact is likely to be even more devastating, potentially reversing recent gains made in the management of other communicable diseases. Of particular concern is the impact of the COVID-19 pandemic on malaria. COVID-19 has been slow to arrive and spread across Africa; nevertheless, there are many reasons to be concerned about malaria within the current context of the COVID-19 pandemic.

Children sleeping on a mattress on the floor and covered by a mosquito net © Vanuata 2012

The virus that causes COVID-19, the SARS-CoV-2 virus, has rapidly spread across the world. On April 23, there were more than 2.7 million reported cases and 192,000 deaths globally. As the pandemic continues its path to low and low-middle income countries (LMICs), its impact is likely to be even more devastating, potentially reversing recent gains made in the management of other communicable diseases.

Of particular concern is the impact of the COVID-19 pandemic on malaria. There were an estimated 228 million cases of malaria and it caused 405,000 deaths in 2018. Sub-Saharan Africa accounted for approximately 93% of all cases and 94% of deaths, with more than two-thirds of deaths occurring among children below the age of five. The majority of people in malaria-endemic countries live in poverty and already face struggling health care systems and a scarcity of skilled health workers, both of which present additional barriers to accessing health care services. Nonetheless, progress in tackling malaria in the past 15 years has been notable. Both cases and deaths due to malaria have declined by about 50% since 2000. During this period, an additional eleven countries were declared malaria free by the World Health Organization (WHO). However, since 2014, due to extrinsic challenges (of which financing was one), progress has stalled. Without any risk mitigation strategies, disruption to malaria programs as a result of the spread of COVID-19 in malaria-endemic countries will set progress back even further.

Read the full blog on the Centre for Tropical Medicine & Global Health website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.